**Core Concept**
Neostigmine is a cholinesterase inhibitor used to reverse nondepolarizing neuromuscular blockade. It works by increasing the concentration of acetylcholine (ACh) at the neuromuscular junction, thereby overcoming the blockade caused by nondepolarizing muscle relaxants.

**Why the Correct Answer is Right**
Neostigmine exerts its effects by inhibiting acetylcholinesterase, the enzyme responsible for breaking down ACh. This leads to an accumulation of ACh in the synaptic cleft, which in turn stimulates muscarinic and nicotinic receptors. The increased nicotinic receptor activity at the neuromuscular junction competes with and eventually surpasses the blocking action of nondepolarizing muscle relaxants, reversing the neuromuscular blockade.

**Why Each Wrong Option is Incorrect**
* **Option A:** Incorrect because neostigmine does not directly stimulate muscarinic receptors, which are involved in the parasympathetic nervous system's effects on the heart, smooth muscle, and glands. While muscarinic receptor activation contributes to some of neostigmine's side effects, it is not a primary mechanism for reversing nondepolarizing blockade.
* **Option B:** Incorrect because neostigmine does not increase the release of ACh from the motor neuron. Instead, it increases the concentration of ACh in the synaptic cleft by inhibiting its breakdown.
* **Option C:** Incorrect because neostigmine does not decrease the binding affinity of nondepolarizing muscle relaxants to the nicotinic receptor. Its mechanism is primarily through increasing ACh concentration, not altering the binding affinity of the muscle relaxants.

**Clinical Pearl / High-Yield Fact**
It's essential to note that neostigmine is most effective when administered in the presence of residual neuromuscular blockade. Administering neostigmine too early, when the blockade is still potent, may not be effective, and administering it too late, when the blockade has largely resolved, may not be necessary.

**Correct Answer: A.**